Alambic Investment Management, L.P. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 162 filers reported holding IMMUNOGEN INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q1 2018$264,000
+79.6%
25,081
+9.5%
0.04%
+105.6%
Q4 2017$147,000
-90.6%
22,912
-88.7%
0.02%
-89.4%
Q3 2017$1,558,000
+477.0%
203,597
+435.6%
0.17%
+415.2%
Q2 2017$270,000
+250.6%
38,015
+32.5%
0.03%
+83.3%
Q3 2016$77,000
-67.9%
28,700
-63.2%
0.02%
-70.0%
Q2 2016$240,00078,0000.06%
Other shareholders
IMMUNOGEN INC shareholders Q2 2017
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders